Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 13INDUSTRY 4NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Urinary Bladder Neoplasms 1Urethral Neoplasms 1Melanoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large B-Cell, Diffuse 1

Interventions

romidepsin 1imetelstat 1Vincristine 1Prednisone 1Polymerase Chain Reaction 1Gemcitabine 1Doxorubicin 1Dexamethasone 1Cytogenetic Analysis 1Cyclophosphamide 1Cisplatin 1Chromosome Mapping 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, T-Cell, Peripheral × romidepsin × Clear all
NCT01846390 2026-03-27

Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma

Canadian Cancer Trials Group

Phase 1 Completed
21 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡